efaproxiral has been researched along with Cancer of Lung in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ayoub, J; Boyd, AP; Cagnoni, PJ; Choy, H; Curran, WJ; Hamburg, S; Kleinberg, L; Kreisman, H; Nabid, A; Roa, W; Scott, C; Smith, C; Souhami, L; Spanos, W; Stea, B | 1 |
Boyd, AP; Cagnoni, PJ; Chang, EL; Fortin, A; Kresl, JJ; Mercier, JP; Nabid, A; Senzer, N; Shaw, E; Stea, B; Suh, JH | 1 |
Cannell, E | 1 |
Amorino, GP; Choy, H; Hercules, SK; Holburn, GE; Lee, H; Paschal, CB; Shyr, Y; Steffen, RP | 1 |
2 trial(s) available for efaproxiral and Cancer of Lung
Article | Year |
---|---|
Phase II multicenter study of induction chemotherapy followed by concurrent efaproxiral (RSR13) and thoracic radiotherapy for patients with locally advanced non-small-cell lung cancer.
Topics: Adult; Aged; Aniline Compounds; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Propionates; Radiation-Sensitizing Agents; Survival Analysis | 2005 |
Phase III study of efaproxiral as an adjunct to whole-brain radiation therapy for brain metastases.
Topics: Adult; Aged; Aniline Compounds; Brain Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Combined Modality Therapy; Cranial Irradiation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Propionates; Radiation Tolerance; Radiation-Sensitizing Agents | 2006 |
2 other study(ies) available for efaproxiral and Cancer of Lung
Article | Year |
---|---|
New hope for old drug in patients with brain metastases.
Topics: Aniline Compounds; Brain Neoplasms; Breast Neoplasms; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Propionates; Radiation-Sensitizing Agents | 2006 |
Enhancement of tumor oxygenation and radiation response by the allosteric effector of hemoglobin, RSR13.
Topics: Allosteric Regulation; Aniline Compounds; Animals; Carcinoma, Large Cell; Hemoglobins; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Mice; Neoplasm Transplantation; Oxygen; Propionates; Radiation-Sensitizing Agents; Tumor Cells, Cultured | 2001 |